Ildong Holdings Co., Ltd.

000230.KS

000230.KSIldong Holdings Co., Ltd.

KSE

7,800.00

KRW

-20.00

(-0.26%)

88.08BMarket Cap

Nov 04Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

KR7000230003

Return %

Stock

S&P500

-42.65

26.87

-41.57

27.51

-26.88

87.04

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	45,261.57	47,134.21	51,419.05	54,211.94	4,977.01	2,172.23	4,037.08	4,373.29	24,584.87	52,821.54	52,460.07	59,823.47	56,540.84	56,967.68
Basic EPS, GAAP	3,545.82	2,194.16	843.67	1,539.38	2,726.18	14,171.43	7.26	-345.71	-1,889.52	-1,699	-6,278	-9,064	-5,277	-3,718.92
Free Cash Flow per Basic Share	3,421.65	-3,415.67	-5,957.99	-573.27	2,176.33	239.77	-435.68	282.06	-39.15	-1,308.86	-4,718.65	-8,477.95	-6,842.03	-3,719.22
Dividend per Share	440.72	566.17	476.28	508.31	631.42	389.9	105.21	194.56	174.88	96.82	105.23	115.85	122.01	0.46
Book Value per Share	34,344.68	35,956.06	36,388.67	37,047.82	38,900.49	28,768.99	5,125.1	-12.59	-2,090.1	79.65	-6,194.75	-14,934.19	-20,396.43	- -
Tangible Book Value per Share	38,858.28	39,984.33	38,767.31	37,999.11	37,490.02	5,621.95	16,982.62	15,216.09	13,154.15	13,433.85	3,042.69	4,400.62	5,257.98	15,020.12
Basic Weighted Avg Shares	8	8	8	8	8	19	10	11	12	11	11	11	11	11
Sales/Revenue/Turnover	348,468	362,781	395,231	417,517	38,301	40,771	41,071	47,050	292,221	596,469	592,375	675,540	638,448	643,298
Operating Margin (%)	11.1	3.85	6.02	3.46	-12.89	-9.16	-4.45	0.04	-8.85	-1.54	-13.79	-14.55	-12.46	3.39
Depreciation Expense	11,229	12,605	14,228	16,357	18,277	12,253	2,503	2,931	20,983	38,245	40,072	39,431	37,945	27,470
Net Income, GAAP	27,299	16,888	6,485	11,856	20,979	265,988	74	-3,719	-22,459	-19,185	-70,891	-102,353	-59,587	-41,995
Effective Tax Rate (%)	21.38	- -	54.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	400.91
Profit Margin (%)	7.83	4.66	1.64	2.84	54.78	652.39	0.18	-7.91	-7.69	-3.22	-11.97	-15.15	-9.33	-6.53
Working Capital	108,347	91,645	101,635	92,301	98,213	30,585	-23,285	-26,780	-61,117	-49,675	-171,687	-168,807	-261,906	271,067
LT Debt	13,400	21,400	64,564	67,590	75,495	30,078	60	43	26,738	46,991	82,331	43,751	42,453	- -
Total Equity	310,172	324,416	326,605	332,950	349,981	106,838	174,057	164,946	323,840	305,608	183,340	169,100	169,902	169,612
Return on Invested Capital (%)	7.32	- -	2.39	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	9.07	- -	2.2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	260.12
Return on Common Equity (%)	12.08	6.24	2.33	4.2	7.18	63.38	0.02	- -	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	56.96%	126.61%	-5.49%
Net Income, GAAP	-314.94%	152.27%	-41.78%
Free Cash Flow	227.19%	656.34%	-19.3%
Total Cash Common Dividend	6.79%	-4.8%	5.31%
Total Equity	3.87%	8.68%	0.47%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Dae-Chang Park
Full Time Employees: 78
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Address: 2, Baumoe-ro 27-gil Seoul South Korea 06752
IPO Date: Invalid Date
Website: www.ildongholdings.co.kr
Business: Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	45,261.57	47,134.21	51,419.05	54,211.94	4,977.01	2,172.23	4,037.08	4,373.29	24,584.87	52,821.54	52,460.07	59,823.47	56,540.84	56,967.68
Basic EPS, GAAP	3,545.82	2,194.16	843.67	1,539.38	2,726.18	14,171.43	7.26	-345.71	-1,889.52	-1,699	-6,278	-9,064	-5,277	-3,718.92
Free Cash Flow per Basic Share	3,421.65	-3,415.67	-5,957.99	-573.27	2,176.33	239.77	-435.68	282.06	-39.15	-1,308.86	-4,718.65	-8,477.95	-6,842.03	-3,719.22
Dividend per Share	440.72	566.17	476.28	508.31	631.42	389.9	105.21	194.56	174.88	96.82	105.23	115.85	122.01	0.46
Book Value per Share	34,344.68	35,956.06	36,388.67	37,047.82	38,900.49	28,768.99	5,125.1	-12.59	-2,090.1	79.65	-6,194.75	-14,934.19	-20,396.43	- -
Tangible Book Value per Share	38,858.28	39,984.33	38,767.31	37,999.11	37,490.02	5,621.95	16,982.62	15,216.09	13,154.15	13,433.85	3,042.69	4,400.62	5,257.98	15,020.12
Basic Weighted Avg Shares	8	8	8	8	8	19	10	11	12	11	11	11	11	11
Sales/Revenue/Turnover	348,468	362,781	395,231	417,517	38,301	40,771	41,071	47,050	292,221	596,469	592,375	675,540	638,448	643,298
Operating Margin (%)	11.1	3.85	6.02	3.46	-12.89	-9.16	-4.45	0.04	-8.85	-1.54	-13.79	-14.55	-12.46	3.39
Depreciation Expense	11,229	12,605	14,228	16,357	18,277	12,253	2,503	2,931	20,983	38,245	40,072	39,431	37,945	27,470
Net Income, GAAP	27,299	16,888	6,485	11,856	20,979	265,988	74	-3,719	-22,459	-19,185	-70,891	-102,353	-59,587	-41,995
Effective Tax Rate (%)	21.38	- -	54.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	400.91
Profit Margin (%)	7.83	4.66	1.64	2.84	54.78	652.39	0.18	-7.91	-7.69	-3.22	-11.97	-15.15	-9.33	-6.53
Working Capital	108,347	91,645	101,635	92,301	98,213	30,585	-23,285	-26,780	-61,117	-49,675	-171,687	-168,807	-261,906	271,067
LT Debt	13,400	21,400	64,564	67,590	75,495	30,078	60	43	26,738	46,991	82,331	43,751	42,453	- -
Total Equity	310,172	324,416	326,605	332,950	349,981	106,838	174,057	164,946	323,840	305,608	183,340	169,100	169,902	169,612
Return on Invested Capital (%)	7.32	- -	2.39	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	9.07	- -	2.2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	260.12
Return on Common Equity (%)	12.08	6.24	2.33	4.2	7.18	63.38	0.02	- -	- -	- -	- -	- -	- -	- -

	Dec'23	Mar'24	Jun'24
Total Current Assets	269,742	258,633	271,067
Accounts Receivable, Net	59,809	60,132	- -
Cash, Cash Equivalents & STI	102,480	85,661	- -
Inventories	91,166	90,676	- -
Total Current Liabilities	- -	- -	- -
Payables & Accruals	- -	- -	- -
ST Debt	282,907	269,080	- -
Deferred Revenue	- -	- -	- -

	Dec'23	Mar'24	Jun'24
ST Debt	282,907	269,080	- -
LT Borrowings	29,877	45,061	- -
LT Finance Leases	12,577	12,261	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	11	11	11
Market Capitalization	118,792	104,340	84,692

Year	Q1	Q2	Q3	Q4	FY
2022	-4,849	1,036	-1,051	- -	-9,064
2023	-1,100	-933.12	-2,262.9	- -	-5,277
2024	-542	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	168,076	171,831	174,216	161,417	675,540
2023	154,055	165,751	160,058	158,583	638,448
2024	161,856	162,801	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	2.65	113.2	- -	- -	115.85
2023	- -	- -	0.46	- -	122.01
2024	- -	- -	- -	- -	- -

Ildong Holdings Co., Ltd.

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Working Capital

Capital Structure

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year